Simcere Pharma (02096) spent approximately 8.0969 million Hong Kong dollars on September 19 to repurchase 1.311 million shares.
Sinopharm Pharmaceutical (02096) announced on September 19, 2024 that it will spend approximately HK$80.969 million to repurchase...
SIMCERE PHARMA (02096) announced on September 19, 2024 that it would spend approximately HK$8.0969 million to repurchase 1.31 million shares at a repurchase price of HK$6.1-6.21 per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
